ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
48.44
-2.02 (-4.00%)
Nov 21, 2025, 3:04 PM CST
167.62%
Market Cap21.75B
Revenue (ttm)1.02B
Net Income (ttm)-429.58M
Shares Out449.03M
EPS (ttm)-0.95
PE Ration/a
Forward PE107.64
Dividendn/a
Ex-Dividend Daten/a
Volume5,218,950
Average Volume8,431,996
Open50.70
Previous Close50.46
Day's Range48.06 - 50.89
52-Week Range15.01 - 81.48
Beta0.62
RSI40.76
Earnings DateOct 30, 2025

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin... [Read more]

Sector Healthcare
Founded 2002
Employees 1,484
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.